HEADER TRANSFERASE 04-JAN-11 2L85 TITLE SOLUTION NMR STRUCTURES OF CBP BROMODOMAIN WITH SMALL MOLECULE OF HBS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BROMO DOMAIN RESIDUES 1081-1197; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15B KEYWDS P53, TRANSFERASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.C.BORAH,S.MUJTABA,I.KARAKIKES,L.ZENG,M.MULLER,J.PATEL,N.MOSHKINA, AUTHOR 2 K.MOROHASHI,W.ZHANG,G.GERONA-NAVARRO,R.J.HAJJAR,M.ZHOU REVDAT 3 01-MAY-24 2L85 1 REMARK SEQADV REVDAT 2 11-MAY-11 2L85 1 JRNL REVDAT 1 19-JAN-11 2L85 0 JRNL AUTH J.C.BORAH,S.MUJTABA,I.KARAKIKES,L.ZENG,M.MULLER,J.PATEL, JRNL AUTH 2 N.MOSHKINA,K.MOROHASHI,W.ZHANG,G.GERONA-NAVARRO,R.J.HAJJAR, JRNL AUTH 3 M.M.ZHOU JRNL TITL A SMALL MOLECULE BINDING TO THE COACTIVATOR CREB-BINDING JRNL TITL 2 PROTEIN BLOCKS APOPTOSIS IN CARDIOMYOCYTES. JRNL REF CHEM.BIOL. V. 18 531 2011 JRNL REFN ISSN 1074-5521 JRNL PMID 21513889 JRNL DOI 10.1016/J.CHEMBIOL.2010.12.021 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.2 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L85 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000102076. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, 3 MM (E)-4-((4-HYDROXYPHENYL)DIAZENYL)BENZENESULFONIC REMARK 210 ACID, 100 MM SODIUM PHOSPHATE, 3 MM [U-100% 2H] DTT, 90% H2O/10% REMARK 210 D2O; 0.5 MM [U-100% 13C; U-100% 15N] PROTEIN, 3 MM (E)-4-((4- REMARK 210 HYDROXYPHENYL)DIAZENYL)BENZENESULFONIC ACID, 100 MM SODIUM REMARK 210 PHOSPHATE, 3 MM [U-100% 2H] DTT, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB; 3D HN(COCA)CB; 3D 1H REMARK 210 -15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 3D 13C-EDITED 13C/15N- REMARK 210 FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ; 600 MHZ; 500 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2.3, NMRVIEW 5.04, CNS REMARK 210 1.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HG3 ARG A 1173 H VAL A 1174 1.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A1078 94.69 58.22 REMARK 500 1 MET A1080 -91.43 57.93 REMARK 500 1 LYS A1082 -64.85 -156.19 REMARK 500 1 PHE A1085 114.99 67.79 REMARK 500 1 ASP A1105 -86.02 29.01 REMARK 500 1 PHE A1111 -58.76 -124.10 REMARK 500 1 ASP A1116 69.66 73.19 REMARK 500 1 LEU A1120 1.65 -64.99 REMARK 500 1 PHE A1126 31.91 -80.79 REMARK 500 1 ASP A1127 -35.78 -130.89 REMARK 500 1 ASN A1131 89.84 -154.83 REMARK 500 1 MET A1133 80.52 25.92 REMARK 500 1 GLN A1148 -1.50 62.41 REMARK 500 1 ASN A1168 12.49 -61.97 REMARK 500 1 ARG A1169 40.93 26.32 REMARK 500 1 LYS A1170 -16.09 68.38 REMARK 500 2 MET A1080 -86.25 63.69 REMARK 500 2 LYS A1082 -79.46 -150.10 REMARK 500 2 PHE A1085 115.39 67.70 REMARK 500 2 ASP A1105 -93.00 34.44 REMARK 500 2 PRO A1110 5.07 -59.51 REMARK 500 2 VAL A1115 152.00 -47.63 REMARK 500 2 LEU A1120 -9.98 -57.25 REMARK 500 2 ASP A1124 37.70 -96.41 REMARK 500 2 PHE A1126 29.86 -78.49 REMARK 500 2 ILE A1128 -58.30 -123.85 REMARK 500 2 MET A1133 106.41 5.43 REMARK 500 2 GLN A1148 -7.89 81.01 REMARK 500 2 ASN A1168 18.52 -68.39 REMARK 500 2 ARG A1169 49.29 22.60 REMARK 500 2 LYS A1170 -9.95 63.51 REMARK 500 2 ARG A1173 -77.18 -53.98 REMARK 500 3 LYS A1083 -121.20 -154.23 REMARK 500 3 ILE A1084 -37.46 -156.46 REMARK 500 3 PHE A1085 -135.88 35.61 REMARK 500 3 ALA A1093 -61.00 -97.99 REMARK 500 3 ASP A1105 -83.90 26.02 REMARK 500 3 PRO A1110 2.30 -56.44 REMARK 500 3 PRO A1114 151.63 -45.42 REMARK 500 3 VAL A1115 29.37 -73.57 REMARK 500 3 ASP A1116 70.92 10.05 REMARK 500 3 LEU A1119 -62.18 -90.36 REMARK 500 3 LEU A1120 3.31 -63.64 REMARK 500 3 ASP A1124 38.10 -96.26 REMARK 500 3 PHE A1126 46.61 -80.27 REMARK 500 3 ASP A1127 -23.37 -143.51 REMARK 500 3 ASN A1131 87.99 -154.70 REMARK 500 3 MET A1133 114.34 57.94 REMARK 500 3 GLN A1148 -11.50 81.62 REMARK 500 3 ASN A1168 20.81 -75.26 REMARK 500 REMARK 500 THIS ENTRY HAS 368 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L85 A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17393 RELATED DB: BMRB REMARK 900 RELATED ID: 2L84 RELATED DB: PDB DBREF 2L85 A 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 SEQADV 2L85 GLY A 1077 UNP Q92793 EXPRESSION TAG SEQADV 2L85 SER A 1078 UNP Q92793 EXPRESSION TAG SEQADV 2L85 HIS A 1079 UNP Q92793 EXPRESSION TAG SEQADV 2L85 MET A 1080 UNP Q92793 EXPRESSION TAG SEQRES 1 A 121 GLY SER HIS MET ARG LYS LYS ILE PHE LYS PRO GLU GLU SEQRES 2 A 121 LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR SEQRES 3 A 121 ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL SEQRES 4 A 121 ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE SEQRES 5 A 121 VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS SEQRES 6 A 121 LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL SEQRES 7 A 121 ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR SEQRES 8 A 121 ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS SEQRES 9 A 121 LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET SEQRES 10 A 121 GLN SER LEU GLY HET L85 A 201 29 HETNAM L85 4-[(E)-(4-HYDROXYPHENYL)DIAZENYL]BENZENESULFONIC ACID FORMUL 2 L85 C12 H10 N2 O4 S HELIX 1 1 LYS A 1086 ARG A 1103 1 18 HELIX 2 2 GLN A 1104 GLN A 1113 1 10 HELIX 3 3 ASP A 1124 VAL A 1129 1 6 HELIX 4 4 ASP A 1134 GLY A 1145 1 12 HELIX 5 5 GLU A 1149 ASN A 1168 1 20 HELIX 6 6 SER A 1172 GLY A 1197 1 26 SITE 1 AC1 8 LEU A1109 LEU A1120 ILE A1122 TYR A1125 SITE 2 AC1 8 TYR A1167 ASN A1168 ARG A1173 VAL A1174 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1